Phase Ib trial of erdafitinib (E) combined with enfortumab vedotin (EV) following platinum and PD-1/L1 inhibitors for metastatic urothelial carcinoma (mUC) with FGFR2/3 genetic alt... von Jain, Rohit K., Heiligh, Jazlyn, Kim, Youngchul, Piekarz, Richard, Pelosof, Lorraine Cheryl, Yang, Yuanquan (Aaron), D'souza, Anishka, Wong, Risa Liang, Graham, Laura, Gupta, Sumati, Park, Anna, Synold, Timothy W., Sonpavde, Guru P.

Volltext